Einzeltreffer — DigiBib

Introduction: Region-specific health-related quality of life (HRQoL) scores or utility values are representative and pivotal for economic evaluations as they are influenced by the value judgment of the local population. This study systematically reviewed and pooled EuroQoL-5 Dimension (EQ-5D) utility scores of rheumatoid arthritis (RA) across primary studies from Asia.

Methods: Studies reporting EQ-5D utility scores among adult RA patients from Asian countries were systematically searched in PubMed-Medline, Scopus and Embase since inception through February 2020. Selected studies were systematically reviewed and study quality assessment was performed. Meta-analysis was performed using a random-effect model with subgroup and meta-regression analysis to explore heterogeneity.

Results: Among 1391 searched articles, 37 studies with 31 983 participants were systematically reviewed and meta-analysis was conducted among 31 studies. The pooled EQ-5D scores and EQ-5D visual analog score were 0.66 (95% CI 0.63-0.69, I 2 = 99.65%) and 61.21 (50.73-71.69, I 2 = 99.56%) respectively with high heterogeneity. For RA patients with no, low, moderate and high disease activity based on Disease Activity Score (DAS)-28, the pooled EQ-5D scores were 0.78 (0.65-0.90), 0.73 (0.65-0.80), 0.53 (0.32- 0.74), and 0.47 (0.32-0.62), respectively. On meta-regression, age of patients (P < .05) was positively associated and use of glucocorticoids (P < .05) was inversely associated with utility values.

Conclusion: Lower EQ-5D scores were associated with severe disease activity, increasing age and female gender among RA patients. The study provides pooled EQ-5D scores for RA patients that are useful inputs for cost-utility studies in Asia.

Titel:	Health-related quality of life in rheumatoid arthritis: Systematic review and meta-analysis of EuroQoL (EQ-5D) utility scores from Asia.
Autor/in / Beteiligte Person:	Haridoss, M ; Bagepally, BS ; Natarajan, M
Link:	Full Text Finder (Volltext)
Zeitschrift:	International journal of rheumatic diseases, Jg. 24 (2021-03-01), Heft 3, S. 314-326
Veröffentlichung:	[Oxford, UK] : Wiley on behalf of the Asia Pacific League of Associations for Rheumatology, 2021
Medientyp:	academicJournal
ISSN:	1756-185X (electronic)
DOI:	10.1111/1756-185X.14066
Schlagwort:	Arthritis, Rheumatoid economics Arthritis, Rheumatoid epidemiology Asia epidemiology Cost-Benefit Analysis Humans Morbidity trends Severity of Illness Index Surveys and Questionnaires Arthritis, Rheumatoid psychology Health Status Psychometrics methods Quality of Life psychology Quality-Adjusted Life Years
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Journal Article; Meta-Analysis; Systematic Review Language: English [Int J Rheum Dis] 2021 Mar; Vol. 24 (3), pp. 314-326. <i>Date of Electronic Publication: </i>2021 Jan 23. MeSH Terms: Health Status* ; Quality-Adjusted Life Years* ; Arthritis, Rheumatoid / psychology ; Psychometrics / methods ; Quality of Life / *psychology ; Arthritis, Rheumatoid / economics ; Arthritis, Rheumatoid / epidemiology ; Asia / epidemiology ; Cost-Benefit Analysis ; Humans ; Morbidity / trends ; Severity of Illness Index ; Surveys and Questionnaires References: Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-2038. ; Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580-1588. ; Malm K, Bergman S, Andersson ML, Bremander A, Larsson I. Quality of life in patients with established rheumatoid arthritis: a phenomenographic study. SAGE Open Med. 2017;5:2050312117713647. ; Jorgensen TS, Turesson C, Kapetanovic M, et al. EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: a prospective observational study of patients registered in the south Swedish SSATG registry. PLoS One. 2017;12(2):e0169946. ; Pal S, Veeravalli SC, Das SK, et al. Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: subgroup data from GO-MORE study. Int J Rheum Dis. 2016;19(11):1083-1092. ; Scott IC, Ibrahim F, Simpson G, et al. A randomised trial evaluating anakinra in early active rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(1):88-93. ; Tanaka Y, Kameda H, Saito K, et al. Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study. Mod Rheumatol. 2020;31(1):42-52. ; Teitsma XM, Jacobs JWG, Welsing PMJ, et al. Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy. Rheumatology (Oxford). 2017;56(12):2179-2189. ; Stephen Joel Coons SR, Keininger DL, Hays RD. A comparative review of genericquality-of-life instruments. Pharmacoeconomics. 2000;17(1):13-35. ; Tijhuis GJ, de Jong Z, Zwinderman AH, et al. The validity of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire. Rheumatology (Oxford). 2001;40(10):1112-1119. ; Excellence NIfHaC. Guide to the Methods of Technology Appraisal. London: NICE; 2008:1-76. ; Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: past, present and future. Appl Health Econ Health Policy. 2017;15(2):127-137. ; EuroQol G. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199-208. ; Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol. 1997;36(5):551-559. ; Payakachat N, Ali MM, Tilford JM. Can the EQ-5D detect meaningful change? A systematic review. Pharmacoeconomics. 2015;33(11):1137-1154. ; Thorat T, Lin PJ, Neumann PJ. The state of cost-utility analyses in Asia: a systematic review. Value Health Reg Issues. 2015;6:7-13. ; Prinja S, Downey LE, Gauba VK, Swaminathan S. Health technology assessment for policy making in India: current scenario and way forward. Pharmacoecon Open. 2018;2(1):1-3. ; Doherty J, Kamae I, Lee KKC, et al. What is next for pharmacoeconomics and outcomes research in Asia? Value Health. 2004;7(2):118-132. ; Park SH, Lee SM. Evidence-based decision-making and health technology assessment in South Korea. Value Health. 2008;11(Suppl 1):S163-S164. ; Péntek M, Rencz F, Golicki D, et al. EQ-5D Studies in rheumatology in eight Central and Eastern European Countries. Value Health. 2016;19:A542. ; Feng J, Campbell S, Norris S. PMS24 A systematic review of existing utility weight estimates in rheumatoid arthritis. Value Health. 2012;15:A675. ; Hoshi D, Tanaka E, Igarashi A, et al. Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database. Mod Rheumatol. 2016;26(1):40-45. ; Katchamart W, Narongroeknawin P, Chanapai W, Thaweeratthakul P. Health-related quality of life in patients with rheumatoid arthritis. Int J Rheum Dis. 2019;22:144. ; Munchey R, Pongmesa T. Health-related quality of life and functional ability of patients with rheumatoid arthritis: a study from a tertiary care hospital in Thailand. Value Health Reg Issues. 2018;15:76-81. ; Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-34. ; Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. ; Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric. 2014;18(6):727-734. ; Downes M, Brennan M, Williams H, Dean R. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6:e011458. ; Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. ; DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. ; Deeks J, Altman D.Effect measures for meta-analysis of trials with binary outcomes. 2008;313-335. ; Egger M, Davey Smith G, Schneider M, Minder C. Bias in Meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629. ; StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC; 2019. ; Anno S, Sugioka Y, Inui K, et al. Evaluation of work disability in Japanese patients with rheumatoid arthritis: from the TOMORROW study. Clin Rheumatol. 2018;37(7):1763-1771. ; Asai S, Kojima T, Takahashi N, Kuwatsuka Y, Ando M, Ishiguro N. Discontinuation of concomitant methotrexate in patients with rheumatoid arthritis treated with tocilizumab: an interventional study. Ann Rheum Dis. 2019;78:1641. ; Bae SC, Cho SK, Won S, et al. Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months. Int J Rheum Dis. 2018;21(5):1001-1009. ; Chen HH, Chen DY, Chen YM, Lai KL. Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan. Clin Rheumatol. 2017;36(1):133-142. ; Cho SK, Kim D, Jun JB, Bae SC, Sung YK. Factors influencing quality of life (QOL) for Korean patients with rheumatoid arthritis (RA). Rheumatol Int. 2013;33(1):93-102. ; Fukuda W, Omoto A, Ohta T, et al. Low body mass index is associated with impaired quality of life in patients with rheumatoid arthritis. Int J Rheum Dis. 2013;16(3):297-302. ; Ghosh P, Hare AD, Kumar VS, Rajmane AR, Adil M, Bodhankar SL. Determination of clinical outcome and pharmacoeconomics of anti-rheumatoid arthritis therapy using CDAI, EQ-5D-3L and EQ-VAS as indices of disease amelioration. Asian Pacif J Trop Dis. 2012;2:S671-S678. ; Hattori Y, Katayama M, Kida D, Kaneko A. Hospital anxiety and depression scale score is an independent factor associated with the EuroQoL 5-dimensional descriptive system in patients with rheumatoid arthritis. J Clin Rheumatol. 2018;24(6):308-312. ; Hirata A, Miyamura T, Suenaga Y, Katayama M, Suematsu E, Tohma S. Latent psychological distress existing behind a set of assessment measures is comparable to or more important than symptoms or disability in the association with quality of life and working status of patients with rheumatoid arthritis. Mod Rheumatol. 2018;28(6):968-975. ; Hu H, Luan L, Yang K, Li SC. Psychometric validation of Chinese Health Assessment Questionnaire for use in rheumatoid arthritis patients in China. Int J Rheum Dis. 2017;20(12):1987-1992. ; Ishikawa H. The latest treatment strategy for the rheumatoid hand deformity. J Orthopaedic Sci. 2017;22(4):583-592. ; Ishikawa H, Abe A, Kojima T, et al. Overall benefits provided by orthopedic surgical intervention in patients with rheumatoid arthritis. Mod Rheumatol. 2019;29(2):335-343. ; Kang J-H, An M, Choi S-E, et al. Performance of the revised 2016 fibromyalgia diagnostic criteria in Korean patients with fibromyalgia. Int J Rheum Dis. 2019;22(9):1734-1740. ; Katchamart W, Narongroeknawin P, Suppa-udom B, Chanapai W, Srisomnuek A. Factors associated with and cutoff points for Patient Acceptable Symptom State (PASS) in rheumatoid arthritis. Clin Rheumatol. 2020;39(3):779-786. ; Kim H-L, Kim D, Jang EJ, et al. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data. Rheumatol Int. 2016;36(4):505-513. ; Kojima T, Ishikawa H, Tanaka S, et al. Target setting for lower limb joint surgery using the Timed Up and Go test in patients with rheumatoid arthritis: a prospective cohort study. Int J Rheum Dis. 2018;21(10):1801-1808. ; Kojima T, Ishikawa H, Tanaka S, et al. Validation and reliability of the Timed Up and Go test for measuring objective functional impairment in patients with long-standing rheumatoid arthritis: a cross-sectional study. Int J Rheum Dis. 2018;21(10):1793-1800. ; Li J, Wen Z, Cai A, et al. Real-world cost-effectiveness of infliximab for moderate-to-severe rheumatoid arthritis in a medium-sized city of China. J Comp Effect Res. 2017;6(3):205-218. ; Lipina M, Makarov M, Mukhanov V, et al. Arthroscopic synovectomy of the knee joint for rheumatoid arthritis. Int Orthop. 2019;43(8):1859-1863. ; Nakajima A, Inoue E, Shimizu Y, et al. Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis. Clin Rheumatol. 2015;34(3):441-449. ; Pal S, Veeravalli SCM, Das SK, et al. Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study. Int J Rheum Dis. 2016;19(11):1083-1092. ; Park EH, Str V, Oh YJ, Song YW, Lee EB. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther. 2019;21(1):61. ; Park H. Association between rheumatoid arthritis and health-related quality of life in Korean women aged 50 years and over. Asian J Pharm Clin Res. 2017;10(5):372-375. ; Patton T, Hu H, Luan L, Yang K, Li SC. Mapping between HAQ-DI and EQ-5D-5L in a Chinese patient population. Qual Life Res. 2018;27(11):2815-2822. ; Seto Y, Inoue E, Shidara K, et al. Functional disability can deteriorate despite suppression of disease activity in patients with rheumatoid arthritis: a large observational cohort study. Mod Rheumatol. 2013;23(6):1179-1185. ; Sung Y-K, Cho S-K, Kim D, et al. Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis. Rheumatol Int. 2017;37(6):975-982. ; Taibanguay N, Chaiamnuay S, Asavatanabodee P, Narongroeknawin P. Effect of patient education on medication adherence of patients with rheumatoid arthritis: a randomized controlled trial. Patient Prefer Adherence. 2019;13:119-129. ; Takeuchi T, Nakajima R, Komatsu S, et al. Impact of adalimumab on work productivity and activity impairment in Japanese Patients with rheumatoid arthritis: large-scale, prospective, single-cohort ANOUVEAU Study. Adv Ther. 2017;34(3):686-702. ; Tanaka Y, Kameda H, Saito K, et al. Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naive rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study. Arthritis Res Ther. 2018;20(1):151. ; Tanaka Y, Kameda H, Saito K, et al. Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study. Mod Rheumatol. 2021;31(1):42-52. ; Uehara M, Takahashi J, Hirabayashi H, et al. Evaluation of clinical results and quality of life after surgical reconstruction for rheumatoid cervical spine. Spine J. 2013;13(4):391-396. ; Uehara M, Takahashi J, Mukaiyama K, et al. Mid-term results of computer-assisted cervical reconstruction for rheumatoid cervical spines. J Orthopaedic Sci. 2013;18(6):916-925. ; Ulutatar F, Duruoz MT. Cervical proprioceptive impairement in patients with rheumatoid arthritis. Ann Rheum Dis. 2018;77:1296. ; Zhang L, Lu GH, Ye S, Wu B, Shen Y, Li T. Treatment adherence and disease burden of individuals with rheumatic diseases admitted as outpatients to a large rheumatology center in Shanghai, China. Patient Prefer Adherence. 2017;11:1591-1601. ; Saraux A, Berthelot JM, Chalès G, et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum. 2001;44(11):2485-2491. ; Zhou T, Guan H, Yao J, Xiong X, Ma A. The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review. Qual Life Res. 2018;27(11):2799-2814. ; Wang HM, Patrick DL, Edwards TC, Skalicky AM, Zeng HY, Gu WW. Validation of the EQ-5D in a general population sample in urban China. Qual Life Res. 2012;21(1):155-160. ; Abdin E, Subramaniam M, Vaingankar JA, Luo N, Chong SA. Measuring health-related quality of life among adults in Singapore: population norms for the EQ-5D. Qual Life Res. 2013;22(10):2983-2991. ; Pham T, Nguyen T, To S, et al. Gender differences in health-related quality of life and health services utilization between elderly men and women in a rural district in Vietnam. Int J Environ Res Public Health. 2018;16:69. ; Tosh JC, Longworth LJ, George E. Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals. Value Health. 2011;14(1):102-109. ; Van den Hout WB, Goekoop-Ruiterman YPM, Allaart CF, et al. Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2009;61(3):291-299. ; Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F. Cost effectiveness analysis of disease-modifying antirheumatic drugs in rheumatoid arthritis. A systematic review literature. Int J Rheumatol. 2011;2011:845496. ; Roudijk B, Donders ART, Stalmeier PFM, et al. Cultural values: can they explain differences in health utilities between countries? Med Decis Making. 2019;39(5):605-616. Grant Information: Department of Health Research, Government of India Contributed Indexing: Keywords: EQ-5D-3L health utility; EQ-5D-5L; rheumatoid arthritis Entry Date(s): Date Created: 20210124 Date Completed: 20211115 Latest Revision: 20211115 Update Code: 20240513

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Health-related quality of life in rheumatoid arthritis: Systematic review and meta-analysis of EuroQoL (EQ-5D) utility scores from Asia.